Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance?

First Trust NYSE Arca Biotechnology Index Fund launches with a more concentrated biotechnology exposure, holding 30 stocks versus 248 holdings in the iShares Biotechnology ETF. The article frames the change as portfolio concentration rather than any earnings or policy catalyst, implying limited near-term price impact.

Analysis

First Trust NYSE Arca Biotechnology Index Fund launches with a more concentrated biotechnology exposure, holding 30 stocks versus 248 holdings in the iShares Biotechnology ETF. The article frames the change as portfolio concentration rather than any earnings or policy catalyst, implying limited near-term price impact.